Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House Human Services hears emotional testimony on bill to allow stock epinephrine in child care; refers measure to education committee
Summary
A Department for Children and Families witness told lawmakers more time is needed to resolve medical, training and regulatory questions about H 574; a parent advocate whose son died urged passage and said other states have implemented similar laws. The committee decided not to vote and will refer the bill to the House Education Committee.
Lawmakers in the House Human Services Committee on April 10 took testimony on H 574, a bill that would permit child‑care programs to maintain undesignated stock epinephrine and train staff to administer it in anaphylactic emergencies.
Deputy Commissioner Janet McLaughlin of the Department for Children and Families told the committee her agency supports the goal of making epinephrine available to children who need it but asked for more time to evaluate "medical, practical and regulatory implications," including dosing for children of different ages, staff training requirements, who would legally hold prescriptions and how licensing rules would need to change.
McLaughlin said schools often have…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
